CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
1,708.00
-28.00 (-1.61%)
Nov 7, 2025, 3:30 PM KST
CMG Pharmaceutical Revenue
CMG Pharmaceutical had revenue of 22.67B KRW in the quarter ending June 30, 2025, a decrease of -8.79%. This brings the company's revenue in the last twelve months to 94.73B, up 1.65% year-over-year. In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B with 5.53% growth.
Revenue (ttm)
94.73B
Revenue Growth
+1.65%
P/S Ratio
2.67
Revenue / Employee
424.78M
Employees
223
Market Cap
252.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
| Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
| Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
| Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
| Dec 31, 2018 | 49.86B | 8.33B | 20.05% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |